Carlsmed, Inc. Reports Results for Quarter Ended June 30, 2026

What Happened

• On August 5, 2026, Carlsmed, Inc. (NASDAQ: CARL) filed a Form 8-K under Item 2.02 to announce its results of operations and financial condition for the quarter ended June 30, 2026. The company issued a press release with those results, which is furnished as Exhibit 99.1 to the filing. The filing was signed by CEO Michael Cordonnier.

Key Details

• Filing date: August 5, 2026 (Form 8-K).
• Reporting period: Quarter ended June 30, 2026.
• Press release: Furnished as Exhibit 99.1 to the 8-K (text incorporated by reference).
• Signature: Form 8-K signed by Michael Cordonnier, Chief Executive Officer and President.

Why It Matters

• This 8-K signals Carlsmed has publicly released its quarterly results (earnings/quarterly results). Retail investors should read the attached press release for revenue, net income or loss, and any management commentary or guidance. The press release may be followed by formal periodic filings (e.g., 10-Q) with full financial statements and disclosures.